biotech
GRI Bio announces two global patents granted for Europe and Japan
April 2, 2025Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent
GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …
Dupixent approved as first biologic medicine in Japan for COPD patients
April 2, 2025Research and Development COPD, Chronic Diseases, Regeneron, Sanofi, biotech, respiratory disease
The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment …
Alfred Merz appointed as CEO of ProBioGen
March 31, 2025Manufacturing Services, Manufacturing and Production CEO, Pharmacy, ProBioGen, appointment, biotech
ProBioGen has announced the appointment of Alfred Merz as its chief executive officer (CEO), effective 1 April 2025. Merz, who …
Carole Imbert appointed as CFO of Vect-Horus
March 28, 2025Biotech/start-up, Sales and Marketing Pharmacy, Vect-Horus, appointment, biotech, cfo
Vect-Horus has announced it has appointed Carole Imbert as chief financial officer (CFO) and to its executive committee. Vect-Horus is …
Ceryx Medical Initiates First-In-Human Study of the Cysoni™ RSA Pacemaker
November 21, 2024Ceryx Medical, Devices, biotech
Ceryx’s Cysoni pacing technology is designed to provide superior therapeutic outcomes for Heart Failure patients by improving cardiac output using …
Novo Holdings Invests in Oxford Nanopore Technologies
August 1, 2024Research and Development Microbiology, Novo Holdings, Oxford Nanopore Technologies, biopharmacuticals, biotech, data, drug therapies, investment
leading life science investor Novo Holdings, announced a £50m investment in Oxford Nanopore Technologies. Oxford Nanopore Technologies is a leading …
Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance
July 10, 2020Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma
Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
Scotland leading the UK in life science start-up growth, report reveals
November 20, 2019Research and Development, Sales and Marketing BioCity, UK, biotech, pharma
A new report published by the life science incubator and business collective BioCity has painted a promising picture of UK …
Biotechnology Innovation Organization Chief to step down after US 2020 elections
October 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotechnology Innovation Organization, US, biotech, pharma
The Biotechnology Innovation Organization (BIO), the largest trade body representing the world’s biotechnology industry, has revealed that its President and …
Darius Hughes, Head of Vaccines Business Unit UK, Pfizer
July 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines
“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …
Gilead invests $5.1 billion into Galapagos NV
July 15, 2019Sales and Marketing Galapagos, Gilead, biotech, collaboration, deal, drug discovery, pharma
Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV. The collaboration will see Gilead invest $5.1 …
Amgen agrees to buy Nuevolution for $167 million
May 22, 2019Research and Development Amgen, Cancer, Nuevolution, biotech, drug discovery, immuno-oncology, immunology, pharma
California biotech Amgen has agreed to buy Danish biopharmaceutical company Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million). The …
MSD buys Peloton Therapeutics in deal worth $2.1 billion
May 22, 2019Research and Development Cancer, MSD, acquisition, biotech, deal, oncology, pharma
MSD has agreed to acquire all outstanding shares in Peloton Therapeutics in a deal worth up to $2.1 billion. US …
Iran ready to export medicines to Venezuela
February 25, 2019Sales and Marketing FDA, Iran, Venezuela, biotech, global, pharma
The chairman of the Iranian Food and Drug Administration (FDA) Mehdi Pirsalehi, has said that Iran is ready to export …
Israeli biotech claims it has developed cure for cancer
January 30, 2019Research and Development Cancer, MuTaTo, biotech, israel, lung cancer, oncology
An Israeli biotech has claimed that it has developed a complete cure for cancer. Speaking to the Jerusalem Post, Dan …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
